MYRIAD GENETICS, INC. Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31)
MYRIAD GENETICS, INC. (MYGN) had Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) of $277.38 million as of 2014-03-31, per its 10-Q filed 2014-05-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost · last filed 2014-05-07
- 2014-03-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $277.38M.
- 2013-12-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $488.49M.
- 2013-09-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $515.52M.
- 2013-06-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $531.50M.
| Period end | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) |
|---|---|
| 2014-03-31 | $277.38M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $488.49M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $515.52M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $531.50M 10-K · filed 2013-08-14 |
| 2013-03-31 | $462.00M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $468.24M 10-Q · filed 2013-02-06 |
| 2012-09-30 | $466.07M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $454.21M 10-K · filed 2012-08-15 |
| 2012-03-31 | $466.70M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $428.31M 10-Q · filed 2012-02-01 |
| 2011-09-30 | $401.70M 10-Q · filed 2011-11-02 |
| 2011-06-30 | $417.08M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |